Event context and recent share performance

Maximus (MMS) has come onto investors’ radar after a period of mixed share performance. The stock is down roughly 22% over the past month and about 15% over the past 3 months.

Against this recent slide, Maximus still has a 1 year total shareholder return of 16.64%. However, the 3 year and 5 year total shareholder returns of 6.02% and 6.59% declines suggest fading longer term momentum.

If Maximus’ move has you reassessing your watchlist, it could be a good moment to widen your view with our screener of 19 top founder-led companies for fresh ideas.

With Maximus trading at $73.87 and sitting at a sizeable discount to both analyst targets and some intrinsic value estimates, you have to ask: is this weakness a chance to buy, or is the market already pricing in future growth?

Most Popular Narrative: 32.8% Undervalued

Maximus’ most followed valuation story pins fair value at $110 per share, well above the last close at $73.87, and it leans heavily on policy tailwinds and technology adoption to justify that gap.

Pending implementation of new federal legislation (e.g. Medicaid work requirements, increased eligibility reviews, and SNAP payment integrity) is set to significantly expand state demand for Maximus' compliance and administration services starting in FY27, positioning the company for an above-trend acceleration in organic revenue growth.

Elevated regulatory complexity and the growing need for technology-driven, outcome-based delivery are fueling increased spend by governments on third-party administrators like Maximus, supporting higher client retention, contract expansion, and strengthening EBITDA and net margins via scale and operational leverage.

Curious what kind of revenue path and margin profile need to line up to support that $110 figure, and how performance based contracts fit in? The full narrative lays out the earnings curve, the assumed profitability shift, and the valuation multiple that ties those forecasts back to today’s price.

Result: Fair Value of $110 (UNDERVALUED)

However, that upside story could be thrown off course if government budgets tighten or if agencies adopt more in-house automation, which could soften contract volumes and margins.

Next Steps

On balance, does this story feel more exciting or concerning to you? Take a moment now to weigh both sides, then check the 5 key rewards and 1 important warning sign to ground your view in the full picture.

Looking for more investment ideas?

If Maximus has sharpened your thinking, do not stop here. Broaden your watchlist now or you risk missing other opportunities already catching informed investors’ attention.

• Spot potential value candidates early by scanning our list of 45 high quality undervalued stocks backed by solid fundamentals and clear, data based checks.
• Strengthen your income focus by reviewing 13 dividend fortresses that pair higher yields with balance sheets our model regularly assesses.
• Unearth off-the-radar opportunities through a screener containing 24 high quality undiscovered gems that many investors may not be watching yet.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.